Cardiovascular problems in peritoneal dialysis patients: A short overview

Peritoneal Dialysis International

Volumn 19, Issue SUPPL. 2, 1999, Pages

  Hoeben, Heidi ^a   Van Biesen, Wim ^a   Lameire, Norbert ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Cardiovascular risk factors; Ischemic heart diseases

Indexed keywords

CARDIOVASCULAR RISK; CONFERENCE PAPER; ECHOCARDIOGRAPHY; HEART FUNCTION; HEMODIALYSIS PATIENT; HUMAN; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RISK FACTOR;

EID: 0033388596     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089901902s24     Document Type: Conference Paper

References (84)

1. Lameire N, Vanholder RC, Van Loo A, Lambert MC, Vijt D, Van Bockstaele L, et al. Cardiovascular diseases in peritoneal dialysis patients: The size of the problem. Kidney Int. 1996; 50(Suppl 56):S28-36.
2. Maiorca R, Cancarini GC, Zubani R, Camerini C, Manili L, Brunori G, et al. CAPD viability: A long-term comparison with hemodialysis. Perit Dial Int. 1996; 16:276-87.
3. Locatelli F, Marcelli D, Conte F, Limido A, Lonati F, Malberti F, et al. 1983 to 1992: Report on regular dialysis and transplantation in Lombardy. Am J Kidney Dis. 1995; 25:196-205.
4. Lameire N, Bernaert P, Lambert MC, Vijt D. Cardiovascular risk factors and their management in patients on continuous ambulatory peritoneal dialysis. Kidney Int. 1994; 46(Suppl 48):S31-8.
5. Viglino G, Cancarini GC, Catizone L, Cocchi R, De Vecchi A, Lupo A, et al. Ten years experience of CAPD in diabetics: Comparison of results with non-diabetics. Nephrol Dial Transplant. 1994; 9:1443-8.
6. Canada-U.S.A. (CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis. Association with clinical outcomes. J Am Soc Nephrol. 1996; 7:198-207.
7. Genestier S, Hedelin G, Schaffer P, Faller B. Prognostic factors in CAPD patients: A retrospective study of a 10-year period. Nephrol Dial Transplant. 1995; 10:1905-11.
8. Harnett JD, Foley RN, Kent GM, Barré PE, Murray D, Parfrey PS. Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors. Kidney Int. 1995; 47:884-90.
9. Foley RN, Parfrey PS, Harnett JD, Kent GM, O'Dea R, Murray DC, et al. Mode of dialysis therapy and mortality in end-stage renal disease. J Am Soc Nephrol. 1998; 9:267-76.
10. Burton PR, Walls J. Selection-adjusted comparison of life-expectancy of patients on continuous ambulatory peritoneal dialysis, hemodialysis, and renal transplantation. Lancet 1987; 1:1115-18.
11. Gault MH, Longerich L, Prabshakaran V, Purchase L. Ischemic heart disease, serum cholesterol and apolipoproteins in CAPD. ASAIO Trans. 1991; 37:M513-14.
12. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barré PE. The outcome and risk factors for left ventricular disorders in chronic uremia. Nephrol Dial Transplant. 1996; 11:1277-85.
13. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995; 47:186-92.
14. Hüting J, Kramer W, Reitinger J, Kuhn K, Wizemann V, Schutterle G. Cardiac structure and function in continuous ambulatory peritoneal dialysis: Influence of blood purification and hypercirculation. Am Heart J. 1990; 119:334-52.
15. Hüting J, Kramer W, Reittinger J, Kuhn K, Schutterle G, Wizemann V. Abnormal diastolic left ventricular filling by pulsed Doppler echocardiography in patients on continuous ambulatory peritoneal dialysis. Clin Nephrol. 1991; 36:21-8.
16. Buonchristiani U, Gamberi G, Misuri S, Carobi C, Giombini L, Di Paolo N. Diastolic left ventricular malfunction in CAPD patients. In: Ota K, Maher J, Winchester J, Hirszel P, eds. Current Concepts in Peritoneal Dialysis. Amsterdam: Excerpta Medica; 1992:681-6.
17. Tabacchi GC, Castiglioni A, Lola P, Giangrande A. Echocardiographic evaluation of left ventricular function in patients on CAPD [Abstract]. Perit Dial Bull. 1987; 7(Suppl 2):S75.
18. Mousson C, Tanter Y, Chalopin JM, Rebibou JM, Dentan G, Morelon P, et al. Traitement de l'insuffisance cardiaque congestive au stade terminal par dialyse péritonéale continue. Evolution à long terme. Presse Med. 1988; 17:1617-20.
19. Deligiannis A, Paschalidou E, Sakellariou G, Vargemezis V, Geleris P, Kontopoulos A, et al. Changes in left ventricular anatomy during haemodialysis, continuous ambulatory peritoneal dialysis and after renal transplantation. Proc EDTA-ERA. 1984; 21:185-9.
20. Leenen FHH, Smith DL, Khanna R, Oreopoulos DG. Changes in left ventricular hypertrophy and function in hypertensive patients started on continuous ambulatory peritoneal dialysis. Am Heart J. 1985; 110:102-6.
21. Eisenberg M, Prichard S, Barré P, Patton R, Hutchinson T, Sniderman A. Left ventricular hypertrophy in end-stage renal disease on peritoneal dialysis. Am J Cardiol. 1987; 60:418-19.
22. Peer G, Korzets A, Hochhauzer E, Eschcar Y, Blum M, Avram A. Cardiac arrhythmia during chronic ambulatory peritoneal dialysis. Nephron. 1987; 45:192-5.
23. McLenachan JM, Dargie HJ. Ventricular arrhythmias in hypertensive left ventricular hypertrophy. Am J Hypertens. 1990; 3:735-40.
24. Canziani ME, Saragosa MA, Draibe SA, Barbieri A, Ajzen H. Risk factors for the occurrence of cardiac arrhythmias in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int. 1993; 13(Suppl 2): S409-11.
25. Canziani ME, Cendoroglo Neto M, Saragoça MA, Cassiolato MA, Ramos OL, Ajzen H, et al. Hemodialysis versus continuous ambulatory peritoneal dialysis: Effects on the heart. Artif Organs. 1995; 19:241-4.
26. Rottembourg J. Residual renal function and recovery of renal function in patients treated by CAPD. Kidney Int. 1993; 43(Suppl 40):S106-10.
27. Tzamaloukas AH, Saddler MC, Murata GH, et al. Symptomatic fluid retention in patients on continuous peritoneal dialysis. J Am Soc Nephrol. 1995; 6:198-206.
28. Lameire N. The impact of residual renal function on the adequacy of peritoneal dialysis. Nephron. 1997; 77:13-28.
29. Heimbürger O, Waniewski J, Werynski A, Tranæus A, Lindholm B. Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney Int. 1990. 38:495-506.
30. Selgas R, Bajo MA, Del Peso G, Jimenez C. Preserving the peritoneal membrane in long-term peritoneal dialysis patients. Semin Dial. 1995; 8:326-32.
31. Martinez-Vea A, Bardaji A, Garcia C, Ridao C, Richart C, Oliver JA. Long-term myocardial effects of correction of anemia with recombinant human erythropoietin in aged patients on hemodialysis. Am J Kidney Dis. 1992; 19:353-7.
32. Fellner SK, Lang RM, Neumann A, Korcarz C, Borow KM. Cardiovascular consequences of correction of the anemia of renal failure with erythropoietin. Kidney Int. 1993; 44:1309-15.
33. Morris KP, Skinner JR, Hunter S, Coulthard MG. Short term correction of anaemia with recombinant human erythropoietin and reduction of cardiac output in end stage renal failure. Arch Dis Child. 1993; 68:644-8.
34. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barré PE. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int. 1996; 49:1379-85.
35. Saldanha LF, Weiler E, Gonick HC. Effect of continuous ambulatory peritoneal dialysis on blood pressure control. Am J Kidney Dis. 1993; 21:184-8.
36. Charra B, Calemard E, Ruffet M, Chazot C, Terrat JC, Vanel T, et al. Survival as an index of adequacy of dialysis. Kidney Int. 1992; 41:1286-91.
37. United States Renal Data System. USRDS 1992 Annual Data Report. IV. Comorbid conditions and correlations with mortality risk among 3,399 incident hemodialysis patients. Am J Kidney Dis. 1992; 5(Suppl 2): 32-8.
38. Iseki K, Miyasato F, Tokuyama K, Nishime K, Uehara H, Shiohira Y, et al. Low diastolic blood pressure, hypoalbuminemia, and risk of death in a cohort of chronic hemodialysis patients. Kidney Int. 1997; 51:1212-17.
39. Iseki K, Kawazoe N, Fukiyama K. Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int. 1993; 44:115-19.
40. Spiegel DM, Breyer JA. Serum albumin: A predictor of long-term outcome in peritoneal dialysis patients. Am J Kidney Dis. 1994; 23:283-5.
41. Acchiardo SR, Moore LW, La Tour PA. Malnutrition as the main factor in the morbidity and mortality of hemodialysis patients. Kidney Int. 1983; 24(Suppl 16): 199-203.
42. Kopple JD. Effect of malnutrition on morbidity and mortality in maintenance dialysis patients. Am J Kidney Dis. 1994; 24:1002-9.
43. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barré PE. Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol. 1996; 7:728-36.
44. Lowrie EG, Laird NM, Parker TF, Sargent JA. Effect of the hemodialysis prescription on patient morbidity. Report from the National Co-operative Dialysis Study. N Engl J Med. 1981; 305:157-65.
45. Foley RN, Parfrey PS, Harnett JD, Kent GM, Hu L, O'Dea R, et al. Hypocalcemia, morbidity, and mortality in end-stage renal disease. Am J Nephrol. 1996; 16:386-93.
46. Massry SG, Smorgorzewski M. Mechanisms through which parathyroid hormone mediates its deleterious effects on organ function in uremia. Semin Nephrol. 1994; 14:219-31.
47. Lacour B, Basile C, Drüeke T, Funck-Brentano JL. Parathyroid function and lipid metabolism in the rat. Miner Electrolyte Metab. 1982; 7:157-65.
48. Stefenelli T, Mayr H, Bergler-Klein J, Globits S, Woloszczuk W, Niederle B. Primary hyperparathyroidism: Incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. Am J Med. 1993; 95:197-202.
49. Totao RD, Lena Vega GL, Grundy SM. Mechanisms and treatment of dyslipidemia of renal diseases. Curr Opin Nephrol Hypertens. 1993. 2:784-90.
50. Auguet T, Senti M, Rubies-Prat J, Pelegri A, Pedro-Botet J, Nogues X, et al. Serum lipoprotein(a) concentration in patients with chronic renal failure receiving haemodialysis: Influence of apolipoprotein(a) genetic polymorphism. Nephrol Dial Transplant. 1993; 8:1099-103.
51. Webb AT, Reaveley DA, O'Donnell M, O'Connor B, Seed M, Brown EA. Lipoprotein (a) in patients on maintenance haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant. 1993; 8:609-13.
52. Koch M, Thomas B, Tschope W, Ritz E. Survival and predictors of death in dialysed diabetic patients. Diabetologia. 1993; 36:1113-17.
53. Cressman MD, Heyka RJ, Paganini EP, et al. Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients. Circulation. 1992; 86:475-82.
54. Goldwasser P, Michel MA, Collier J, Mittman N, Fein PA, Gusik SA, et al. Prealbumin and lipoprotein(a) in hemodialysis: Relationships with patient and vascular access survival. Am J Kidney Dis. 1993; 22:215-25.
55. Bostom AG, Lathrop L. Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int. 1997; 52:10-20.
56. Gupta A, Robinson K. Hyperhomocysteinemia and end stage renal disease. J Nephrol. 1997; 10:77-84.
57. Bachmann J, Tepel M, Raidt H, Riezler R, Graefe U, Zappia V. Hyperhomocysteinemia and the risk of vascular disease in hemodialysis patients. J Am Soc Nephrol. 1995; 6:121-5.
58. Robinson K, Gupta A, Dennis V, Arheart K, Chaudhary D, Green R, et al. Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations. Circulation. 1996; 94:2743-8.
59. Hultberg B, Andersson A, Sterner G. Plasma homocysteine in renal failure. Clin Nephrol. 1993; 40:230-4.
60. Kim S, Hirose S, Tamura H, Nagasawa R, Tokushima H, Mitarai T, et al. Hyperhomocysteinemia as a possible role for atherosclerosis in CAPD patients. In: Khanna R, ed. Advances in Peritoneal Dialysis. Toronto: Peritoneal Dialysis Publications, 1994; 10:282-5.
61. Maggi E, Bellazzi R, Falaschi F, Frattoni A, Perani G, Finardi G, et al. Enhanced LDL oxidation in uremic patients: An additional mechanism for accelerated atherosclerosis? Kidney Int. 1994; 45:876-83.
62. Sutherland WH, Walker RJ, Ball MJ, Stapley SA, Robertson MC. Oxidation of low density lipoproteins from patients with renal failure or renal transplants. Kidney Int. 1995; 48:227-36.
63. Schulz T, Schiffl H, Scheithe R, Hrboticky N, Lorenz R. Preserved antioxidative defense of lipoproteins in renal failure and during hemodialysis. Am J Kidney Dis. 1995; 25:564-71.
64. Maggi E, Bellazzi R, Gazo A, Seccia M, Bellomo G. Autoantibodies against oxidatively-modified LDL in uremic patients undergoing dialysis. Kidney Int. 1994; 46:869-76.
65. Hüting J. Progression of valvular sclerosis in end-stage renal disease treated by long-term peritoneal dialysis. Clin Cardiol. 1992; 15:745-50.
66. Muirhead N, Bargman J, Burgess E, Jindal KK, Levin A, Nolin L, Parfrey P. Evidence-based recommendations for the clinical use of recombinant human erythropoietin. Am J Kidney Dis. 1995; 26(Suppl 1):S1-24.
67. Lewis EJ, Hunsicker LG, Bain RD, Rohde RD. The effeet of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med. 1993; 329: 1456-62.
68. Maschio G, Alberti D, Janin G, Locatelli F, Mann JF, Motolese M, et al. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med. 1996; 334:939-45.
69. Schneider RE, Martas P, Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies. JAMA. 1996; 275:1507-13.
70. London GM, Pannier B, Guerin AP, Marchais SJ, Safar ME, Cuche JL. Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade. Circulation. 1994; 90:2786-96.
71. Bostom AG, Shemin D, Lapane KL, Hume AL, Yoburn D, Nadeau MR, et al. High dose B-vitamin treatment of hyperhomocysteinemia in dialysis patients. Kidney Int. 1996; 49:147-52.
72. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987; 316:1429-35.
73. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991; 325:293-302.
74. Yusuf B, Pepine CJ, Gares C, Pouleur H, Salem D, Kostis J, et al. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet. 1992; 340:1173-8.
75. Pfeffer MA, Braunwald E, Moyé LA, Basta L, Brown EJ, Cuddy TE, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 1992; 327:669-77.
76. Oster JR, Materson BJ. Renal and electrolyte complications of congestive heart failure and effects of therapy with angiotensin-converting enzyme inhibitors. Arch Intern Med. 1992; 152:704-10.
77. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 1997; 336:525-33.
78. Cohn JH, Archibald DG, Ziesche S, Franciosa JA, Hartson WE, Tristani FE, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure: Results of a Veterans Administration Cooperative Study. N Engl J Med. 1986; 314:1547-52.
79. Zaremski DG, Nolan PE, Srack MK, Lui CY. Metaanalysis of the use of low dose beta blockers in idiopathic or ischemic dilated cardiomyopathy. Am J Cardiol. 1996; 77:1247-50.
80. Mckinnie JJ, Bourgeois RJ, Husserl FE. Longterm therapy for heart failure with continuous ambulatory peritoneal dialysis. Arch Int Med. 1985; 145:1128-9.
81. Rubin J, Ball R. Continuous ambulatory peritoneal dialysis as treatment of severe congestive heart failure in the face of chronic renal failure. Report of eight cases. Arch Int Med. 1986; 146:1533-5.
82. Konig PS, Lhotta K, Kronenberg F, Joannidis M, Herold M. CAPD: A successful treatment in patients suffering from therapy-resistant congestive heart failure. In: Khanna R, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, eds. Advances in Peritoneal Dialysis. Toronto: Peritoneal Dialysis Bulletin, 1991; 7:97-101.
83. Ko W, Kreiger KH, Isom OW. Cardiopulmonary bypass procedures in dialysis patients. Ann Thorac Surg. 1993; 55:677-84.
84. Rinehart AL, Herzog CA, Collins AJ, Flack JM, Ma JZ, Opsahl JA. A comparison of coronary angioplasty and coronary artery bypass grafting in chronic dialysis patients. Am J Kidney Dis. 1995; 25:281-90.